Venkateswarlu Jasti

This inventor holds 59 USPTO granted patents and 10 published patent applications, plus 51 CIPO patents and 46 EPO patents, primarily in Pharmaceutical Compositions (CPC class C07D). Top assignees: Suven Life Sciences Limited, Sol-Gel Technologies Ltd., Suven Life Science Limited. Active years: 2007-2026.

USPTO Granted Patents = 59 (Patent Applications = 10)

% Patents Active = 66.1

CIPO Patents = 51 (Patent Applications = 8)

EPO Patents = 46 (Patent Applications = 45)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 54(Granted Patents)

Forward Citations (Not Self Cited) = 45(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Adhra Pradesh, IN (2009 - 2011)
Andhra Pradesh, IN (2012 - 2017)
Telangana, IN (2019 - 2022)
Hyderabad, IN (2007 - 2023)

Company Filing History:

53 out of 55

Suven Life Sciences Limited

patents

2 out of 41

Sol-Gel Technologies Ltd.

patents

1 out of 1

Suven Life Science Limited

patent

4. 1 out of 1

Suven Sciences Limited

patent

5. 2 out of 834,411

Other

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

5-HT4 Receptor Agonists

Muscarinic M1 Modulators

CNS Disorders

Histamine H3 Receptor

Piperidine Compounds

Polycyclic Amides

Acetylcholinesterase Inhibitors

Sulfone Compounds

Benzoisothiazole

Pyrrolo-Pyridazine Derivatives

Triple Combination Therapies

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721846 - Methods for treating behavioral and psychological symptoms in patients with dementia (2026-09-01),

2. 12629365 - Pharmaceutical compositions of 5-HTreceptor antagonist (2026-05-19),

3. 12397003 - Amorphous pharmaceutical compositions of abiraterone acetate (2025-08-26),

4. 12391698 - Substituted piperidines and piperazines and methods for the treatment of CNS disorders (2025-08-19),

5. 12338236 - Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders (2025-06-24),

6. 12285421 - Uses of a 5-HT4 receptor agonist (2025-04-29),

7. 12275746 - Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists (2025-04-14),

8. 12156871 - Substituted azacycles as muscarinic M1 receptor positive allosteric modulators (2024-12-03),

9. 12122779 - Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators (2024-10-22),

10. 11622967 - Method of treatment with histamine-3 receptor inverse agonist (2023-04-11),

11. 11458135 - Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors (2022-10-04),

12. 11278530 - Polycyclic amides as muscarinic M1 receptor positive allosteric modulators (2022-03-22),

13. 11253514 - Triple combination of pure 5-HTreceptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist (2022-02-22),

14. 11234979 - Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators (2022-02-01),

15. 11116764 - Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist (2021-09-14),

Title: Inventor Venkateswarlu Jasti - Revolutionizing Technology in Hyderabad

Introduction: Venkateswarlu Jasti is a visionary inventor based in Hyderabad, India, known for his groundbreaking contributions to the field of technology.

Latest Patents: Venkateswarlu Jasti holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare innovations.

Career Highlights: With a career spanning over two decades, Jasti has worked with leading research institutions and tech companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Venkateswarlu Jasti has collaborated with top universities, multinational companies, and research institutions to bring his inventions to life and make a difference in the world.

Conclusion: Venkateswarlu Jasti's relentless pursuit of innovation and his passion for creating transformative technologies continue to inspire the next generation of inventors and entrepreneurs.